Group 1 - Oscar Health, Inc. (OSCR) stock closed at $15.53, down 3.42% from the previous day, underperforming the S&P 500's gain of 0.28% [1] - The stock has increased by 13.64% over the past month, outperforming the Finance sector's gain of 2.79% and the S&P 500's gain of 4.37% [1] Group 2 - Oscar Health, Inc. is expected to report an EPS of $0.34, reflecting a 70% increase from the same quarter last year, with revenue forecasted at $2.86 billion, indicating a 28.96% growth [2] - For the fiscal year, earnings are projected at $0.61 per share and revenue at $11.21 billion, representing increases of 510% and 22.12% respectively from the prior year [3] Group 3 - Recent analyst estimate revisions for Oscar Health, Inc. indicate positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Oscar Health, Inc. at 3 (Hold), with the consensus EPS projection remaining unchanged over the past 30 days [6] Group 4 - Oscar Health, Inc. has a Forward P/E ratio of 26.22, significantly higher than the industry average of 10.14, suggesting the company is trading at a premium [7] - The Insurance - Multi line industry, part of the Finance sector, holds a Zacks Industry Rank of 65, placing it in the top 27% of over 250 industries [7]
Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade